Kenneth Bahrt insider trades: Oncobiologics (ONS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kenneth reports to the SEC
Open-market buys and sales
11 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 25, 2018 | ONS | ↓ Sell | 7,700 | $0.85 | $7K | Direct | Jun 27, 2018 (2d) |
| Dec 22, 2017 | ONS | ↓ Sell | 26,165 | $1.13 | $30K | Direct | Dec 26, 2017 (4d) |
| Oct 16, 2013 | SVNT | ↓ Sell | 78,211 | $0.08 | $6K | Direct | Oct 17, 2013 (1d) |
| Apr 30, 2013 | SVNT | ↓ Sell10b5-1 | 1,250 | $0.74 | $925 | Direct | May 1, 2013 (1d) |
| Feb 4, 2013 | SVNT | ↓ Sell10b5-1 | 29,000 | $1.03 | $30K | Direct | Feb 6, 2013 (2d) |
| Jan 31, 2013 | SVNT | ↓ Sell10b5-1 | 1,300 | $1.03 | $1K | Direct | Feb 4, 2013 (4d) |
| Oct 31, 2012 | SVNT | ↓ Sell10b5-1 | 1,000 | $1.45 | $1K | Direct | Nov 6, 2012 (6d) |
| Aug 1, 2012 | SVNT | ↓ Sell10b5-1 | 4,950 | $0.62 | $3K | Direct | Aug 3, 2012 (2d) |
| Nov 16, 2011 | SVNT | ↑ Buy | 5,000 | $2.59 | $13K | Direct | Nov 18, 2011 (2d) |
| Sep 14, 2011 | SVNT | ↑ Buy | 2,500 | $3.95 | $10K | Direct | Sep 16, 2011 (2d) |
| Sep 14, 2011 | SVNT | ↑ Buy | 500 | $3.97 | $2K | By father as UTMA custodian for son | Sep 16, 2011 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Kenneth Bahrt's insider trades
Kenneth Bahrt is Chief Medical Officer at Oncobiologics (ONS). Since Sep 14, 2011, Kenneth has reported 3 open-market purchases worth $25K and 8 sales worth $79K on SEC Form 4. There have been no open-market trades in the last 12 months.
5 sales (46% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (6 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ONS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.